株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

組換えC因子アッセイ - 世界市場の将来展望(2019年~2027年)

Recombinant Factor C Assay - Global Market Outlook (2019-2027)

発行 Stratistics Market Research Consulting 商品コード 942435
出版日 ページ情報 英文 171 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
組換えC因子アッセイ - 世界市場の将来展望(2019年~2027年) Recombinant Factor C Assay - Global Market Outlook (2019-2027)
出版日: 2020年06月01日 ページ情報: 英文 171 Pages
概要

世界の組み換えC因子アッセイ市場は、2019年に1,429万米ドルとなり、予測期間中に9.9%のCAGRで成長し、2027年までに3,040万米ドルに達すると予測されています。代替のエンドトキシン検出テストの必要性の高まりとオペレーターのリスクの軽減を支援することによるコストのメリットなどが、市場成長を促進する主な要因となっています。ただし、rFCの未知のサンプルの組み合わせテストを検証する長期的な研究の欠如が、市場成長を妨げています。

当レポートでは、世界の組換えC因子アッセイ市場について調査分析し、市場概要、市場動向、市場区分、地域別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • エンドユーザー分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の組換えC因子アッセイ市場:エンドユーザー

  • 開発業務受託機関(CRO)
  • バイオテクノロジー企業
  • 医療機器会社
  • 製薬会社

第6章 世界の組換えC因子アッセイ市場:ブランド別

  • EndoNext
    • Endozyme II GO
    • EndoLisa
    • Endozyme II
  • PyroGene
    • PyroGene rFC(192テスト)
    • PyroGene Bulk rFC(2,880テスト)

第7章 世界の組換えC因子アッセイ市場: 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東・アフリカ

第8章 主要動向

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • M&A
  • 新製品の発売
  • 拡張
  • その他の主な戦略

第9章 企業プロファイル

  • Hyglos GmbH - a bioMerieux Company
  • Lonza Group
図表

List of Tables

  • Table 1 Global Recombinant Factor C Assay Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 3 Global Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 4 Global Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 5 Global Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 6 Global Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 7 Global Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 8 Global Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 9 Global Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 10 Global Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 11 Global Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 12 Global Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 13 Global Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 14 Global Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 15 North America Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 16 North America Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 17 North America Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 18 North America Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 19 North America Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 20 North America Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 21 North America Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 22 North America Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 23 North America Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 24 North America Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 25 North America Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 26 North America Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 27 North America Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 28 North America Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 29 Europe Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 30 Europe Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 31 Europe Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 32 Europe Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 33 Europe Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 34 Europe Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 35 Europe Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 36 Europe Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 37 Europe Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 38 Europe Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 39 Europe Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 40 Europe Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 41 Europe Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 42 Europe Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 43 Asia Pacific Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 44 Asia Pacific Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 45 Asia Pacific Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 46 Asia Pacific Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 47 Asia Pacific Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 48 Asia Pacific Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 49 Asia Pacific Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 50 Asia Pacific Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 51 Asia Pacific Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 52 Asia Pacific Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 53 Asia Pacific Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 54 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 55 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 56 Asia Pacific Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 57 South America Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 58 South America Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 59 South America Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 60 South America Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 61 South America Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 62 South America Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 63 South America Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 64 South America Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 65 South America Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 66 South America Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 67 South America Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 68 South America Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 69 South America Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 70 South America Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
  • Table 71 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
  • Table 72 Middle East & Africa Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
  • Table 73 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
  • Table 74 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
  • Table 75 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
  • Table 76 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
  • Table 77 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
  • Table 78 Middle East & Africa Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
  • Table 79 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
  • Table 80 Middle East & Africa Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
  • Table 81 Middle East & Africa Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
  • Table 82 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
  • Table 83 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
  • Table 84 Middle East & Africa Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
目次

According to Stratistics MRC, the Global Recombinant Factor C Assay Market is accounted for $14.29 million in 2019 and is expected to reach $30.40 million by 2027 growing at a CAGR of 9.9% during the forecast period. The rise in need of alternative endotoxin detection tests and cost advantages by helping in reducing the operator risks is propelling the market growth. However, the lack of long-term studies that validate rFC for combination testing of unknown samples is hampering the market growth.

Recombinant factor C (rFC) assay is an alternative to LAL tests utilized for endotoxin testing of the products for pyrogens. Recombinant factor C (rFC) assay is a synthetic correspondent of Factor C and is the first part of the horseshoe crab clotting cascade, which is activated in response to endotoxins.

Based on the brand, the PyroGene segment is going to have a lucrative growth during the forecast period as it is being the first marketed rFC assay product used as an alternative to LAL tests and also it is one of the main products tested as an alternative to LAL tests to conserve the Limulus species. By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to incorporation of rFC as a recognized endotoxin detection test by pharmacopoeias, and focus on conservation of the Limulus species.

Some of the key players profiled in the Recombinant Factor C Assay Market include Hyglos GmbH - a bioMerieux Company and Lonza Group.

End Users Covered:

  • Contract Research Organizations (CROs)
  • Biotechnology Companies
  • Medical Device Companies
  • Pharmaceutical Companies

Brands Covered:

  • EndoNext
  • PyroGene

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Recombinant Factor C Assay Market, By End User

  • 5.1 Introduction
  • 5.2 Contract Research Organizations (CROs)
  • 5.3 Biotechnology Companies
  • 5.4 Medical Device Companies
  • 5.5 Pharmaceutical Companies

6 Global Recombinant Factor C Assay Market, By Brand

  • 6.1 Introduction
  • 6.2 EndoNext
    • 6.2.1 Endozyme II GO
    • 6.2.2 EndoLisa
    • 6.2.3 Endozyme II
  • 6.3 PyroGene
    • 6.3.1 PyroGene rFC (192 tests)
    • 6.3.2 PyroGene Bulk rFC (2,880 tests)

7 Global Recombinant Factor C Assay Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Hyglos GmbH - a bioMerieux Company
  • 9.2 Lonza Group